Institutional Experience. Entrepreneurial Execution.
Vital Capital Partners (VCP) is a vertically integrated real estate investment platform that acquires, invests in and actively manages institutional-quality healthcare-centric properties throughout the United States. We believe that the demand for healthcare real estate facilities will steadily increase over the next decade as a result of a variety of demographic, economic and regulatory trends.
About Vital Capital Partners
We leverage our national relationships for proprietary deal flow access with health systems and physician groups, as well as local and regional build-to-suit developers who seek to monetize assets through outright sale or sale-leaseback transactions. VCP invests in what has been a historically recession-resilient ambulatory medical asset class, as well as more niche specialty outpatient healthcare real estate that has proven to provide steady, long-term cash flows, rent stability and predictable occupancy patterns.
VCP’s platform is vertically integrated, with capabilities across property and construction management, asset management, equity and debt capital markets, and leasing and transaction management - led by an executive team, each with 20+ years of experience in the medical/healthcare real estate sector.
Our Team
The principals of Vital Capital Partners (VCP) have formed a strategic relationship that combines one of the industry’s most experienced middle-market healthcare real estate operating team with an 85+ year old institutional capital management and investment platform. Together, our collaboration will deliver institutional-quality investment opportunities with attractive risk-adjusted returns to accredited investors through the private wealth channel, a segment historically underserved in the medical real estate market.
Robert Lee
Co-Managing Partner
Thuy Turner
Co-Managing Partner
In 2024, Robert Lee and Thuy Turner co-founded Vital Capital Partners (VCP) as a Delaware Statutory Trust (DST) real estate platform with the goal of providing accredited investors access to carefully vetted opportunities backed by institutional-level underwriting and technical expertise.
Prior to VCP, Mr. Lee and Ms. Turner have worked closely as a team at Healthcare Property Advisors (HPA) and affiliated companies since 2016 – which acquired, operated, and successfully exited over $500 million of medical and healthcare real estate through a previously managed institutional healthcare real estate fund. Based in Southern California, the company has deep relationships with a large network of health systems, physician groups, developers and brokers.
© Vital Capital Partners. All Rights Reserved.
Statistical data is as of January 2026. Figures are subject to change.
This is for informational purposes only and should not be relied upon as tax or legal advice. Vital Capital Partners does not offer legal or tax advice. Because investor situations and objectives vary this information is not intended to indicate that an investment is appropriate for or is recommended to any individual investor. Please consult the appropriate professional regarding your individual circumstance.
This is neither an offer to sell nor a solicitation of an offer to buy securities described herein. An offering is made only by the Confidential Private Placement Memorandum (PPM). All sale and advertising literature must be read in conjunction with the PPM in order to understand fully all of the implications and risks of the offering to which it relates. A copy of the PPM must be made available to you in connection with an offering. Prospective Members should carefully read the PPM and review any additional information they desire prior to making an investment and should be able to bear the complete loss of their investment.
There are material risks associated with investing in private placements and real estate securities including illiquidity, speculation, general market conditions, interest rate risks, financing risks, potentially adverse tax consequences, general economic risks, development risks, and potential loss of the entire investment principal. Prospective investors should perform their own due diligence carefully and review the “Risk Factors” section of any prospectus, private placement memorandum or offering circular before considering any investment.
DST 1031 properties are only available to accredited investors or accredited entities. If you are unsure if you are an accredited investor and/or an accredited entity, please verify with your CPA and Attorney.
An accredited investor is typically defined as having a $1 million net worth excluding primary residence or $200,000 income individually/$300,000 jointly of the last two years; or have an active Series 7, Series 82, or Series 65. Individuals holding a Series 66 do not fall under this definition) and accredited entities only.
An accredited entity is typically a private business development company or an organization with assets exceeding $5 million; or if an entity consists of equity owners who are accredited investors, the entity itself is an accredited investor provided the organization was not formed with a sole purpose of purchasing specific securities.
Potential cash flows/returns/appreciation are not guaranteed and could be lower than anticipated. Diversification does not guarantee a profit or protect against a loss in a declining market. It is a method used to help manage investment risk.
All forward-looking statements address matters that involve risks and uncertainties and investors should be able to bear the loss of their entire investment. All investors should make their own determination of whether or not to make any investment, based on their own independent evaluation and analysis. Past performance is not indicative of future returns or Fund results. Individual investment performance, examples provided and/or case studies are not indicative of overall returns of the Company. In addition, there can be no guarantee of deal flow in the future. Forward looking statements are not statements of historical fact and reflect the Company’s views and assumptions regarding future events and performance.
The securities are offered in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended, and are not required to comply with specific disclosure requirements that apply to registration under the Securities Act. Neither the SEC nor any state regulator has reviewed the merits of or given its approval to the securities, the terms of the offerings, or the accuracy or completeness of any offering materials. The securities are subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell their securities.
Vital Capital Partners (“VCP”) offers securities through American Alternative Capital, LLC (AAC), a member FINRA / SIPC. VCP and AAC are independent of each other. For more information on AAC, please visit BrokerCheck.